You are here
NanoVibronix to Present at Dawson James Securities 4th Annual Small Cap Growth Conference
ELMSFORD, N.Y., Oct. 22, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that Brian Murphy, Chief Executive Officer, will be presenting at the Dawson James Securities 4th Annual Small Cap Growth Conference on Tuesday, October 30th, at 4:00 PM, Eastern Time, at the Wyndham Grand Hotel in Jupiter, Florida.
About Dawson James Securities
Dawson James Securities, Inc., a member of FINRA/SIPC, is a full-service investment bank headquartered in Boca Raton, FL. http://www.dawsonjames.com.
NanoVibronix Inc. (NASDAQ: NAOV) is a medical device company headquartered in Elmsford, NY with research and development in Nesher, Israel, that is focused on developing medical devices utilizing its proprietary and patented low intensity surface acoustic wave technology. The company's technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including the disruption of biofilms and bacteria colonization, as well as providing pain relief. The devices can be administered at home, without the assistance of medical professionals. The company's primary products include PainShield®, UroShield™ and WoundShield™. Additional information about the company is available at: www.nanovibronix.com.